Abstract Introduction Cancer disparities among US Latinos, who account for 19.1% of the total population, persist as a significant public health challenge, characterized by poor outcomes throughout the cancer continuum. Cancer is often diagnosed at a later stage in Latino patients, making treatment more challenging, and they are less likely to receive timely 2025 Sep 18-21; Baltimore, MD. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2025;34(9 Suppl):Abstract nr B114.
Muñoz et al. (Thu,) studied this question.